Biophytis SA Sponsored ADR BPTSY
0.25
0.00
0.00%
as of 24 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow BPTSY
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
2.02 | 5.95 | 2.34 | 0.75 | 1.31 | 1.37 | 0.96 | 0.72 | 0.25 |
Net Debt/EBITDA |
0.21 | 1.61 | 0.44 | (0.42) | 1.04 | 0.25 | (0.13) | (0.18) | (1.24) |
Debt/Assets |
12.98% | 0.00% | 32.05% | 79.23% | 33.43% | 51.47% | 66.31% | 69.15% | 142.60% |
Debt/Equity |
0.24 | 0.01 | 1.00 | (1.85) | 1.33 | 3.27 | (7.63) | (2.13) | (1.01) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.83 | 0.76 | 0.91 | 0.92 | 0.58 | 0.76 | 0.78 | 0.76 | 0.83 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | (0.05) | (0.69) | (0.17) | (0.20) | 0.01 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (55.17%) | (90.58%) | (95.69%) | 9,235.28% | 5,835.11% | (508.01%) | (1,077.40%) | 592.38% | 152.74% | |
| (41.76%) | (311.18%) | (128.21%) | (89.06%) | (76.56%) | (99.93%) | (77.24%) | (102.06%) | (110.04%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,417.57%) | 0.00% | 0.00% |
Return on Tangible Assets |
(244.36%) | (57.60%) | (123.05%) | 373.07% | (295.72%) | (342.95%) | 12,879.35% | 532.07% | 90.63% |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.25 | 0.00 | 0.09 | 0.14 | 0.10 | 0.08 | 0.12 | 0.22 | 0.38 |
Share Based Compensation of Revenue |
— | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(8.42) | (6.63) | (36.96) | (36.63) | (767.48) | (964.83) | (461.20) | (104.35) | (180.00) |
Cash per Share |
3.90 | 15.10 | 41.68 | 14.20 | 1,429.47 | 1,005.44 | 280.71 | 47.30 | 5.59 |
Shareholders Equity per Share |
5.79 | 16.13 | 20.23 | (16.89) | 520.28 | 228.03 | (46.07) | (30.99) | (202.28) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.79 | 16.13 | 20.23 | (16.89) | 520.28 | 228.03 | (46.07) | (30.99) | (202.28) |
Free Cash Flow |
(6.96) | (10.51) | (14.68) | (18.37) | (11.51) | (28.56) | (20.15) | (14.17) | (9.34) |
Working Capital |
3.14 | 23.49 | 12.73 | (5.57) | 6.46 | 10.11 | (0.81) | (3.80) | (12.64) |
Capital Expenditures |
(0.14) | (0.15) | (0.13) | (0.32) | (0.24) | (0.41) | (0.15) | (0.24) | 0.01 |
Net Current Asset Value |
2.12 | 22.50 | 5.17 | (11.79) | 4.15 | 1.34 | (5.61) | (7.57) | (13.72) |
| Other line items | |||||||||
Quick Ratio |
1.93 | 5.87 | 2.28 | 0.72 | 1.31 | 1.37 | 0.96 | 0.72 | 0.25 |
Depreciation/Fixed assets |
0.61 | 0.65 | 0.77 | 1.42 | 40.83 | 0.88 | 1.45 | 3.41 | 3.24 |
Cash ROIC |
(79.17%) | (21.93%) | (46.03%) | (129.56%) | (28.76%) | (49.19%) | (80.50%) | (127.84%) | (2,174.50%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.08 | 0.00 | 0.12 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
4,196.41 | 0.00 | 3,233.77 | 3,678.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
244.79 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(8.42) | (6.63) | (36.96) | (36.63) | (751.18) | (951.08) | (457.80) | (102.60) | (180.20) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (16.30) | (13.75) | (3.40) | (1.75) | 0.21 |
Average Receivables |
3.32 | 3.32 | 4.57 | 6.97 | 7.36 | 6.86 | 7.52 | 5.23 | 3.56 |
Average Payables |
2.17 | — | 2.17 | 2.64 | 6.04 | 9.06 | 8.16 | 6.57 | 5.23 |
Average Assets |
20.05 | 4.42 | 12.54 | 22.44 | 25.44 | 36.99 | 33.03 | 18.05 | 10.21 |
Average Common Equity |
15.18 | 15.18 | 16.80 | (0.22) | (0.33) | 7.28 | 2.37 | (3.11) | (7.35) |
Capex to Sales |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates